Vepacel

(prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture))

Uses, side effects, dosage information & price range

Ology Bioservices Ireland LTD

About this medicine

Active immunisation against H5N1 subtype of influenza A virus. This indication is based on immunogenicity data from subjects from the age of 6 months onwards following administration of two doses of vaccine prepared with H5N1 subtype strains. Vepacel should be used in accordance with Official guidance.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

FocliviaComposition: pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)Seqirus S.r.l.

Price on RequestView Details →

PandemrixComposition: influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.

Price on RequestView Details →

FocetriaComposition: influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)Novartis Vaccines and Diagnostics S.r.l.

Price on RequestView Details →

ArepanrixComposition: pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.

Price on RequestView Details →

Key Information

Salt / Composition

prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture)